mCRPC: Survival with enzalutamide and abiraterone improved in Blacks vs WhitesNovember 15, 2021Prostate Cancer
Prostate cancer: Surgery shows survival advantage in high-risk African AmericansNovember 15, 2021Prostate Cancer
Prostate cancer screening: Racial disparities in MRI use after elevated PSA resultsNovember 15, 2021Prostate Cancer
Prostate cancer: Salvage LDR brachytherapy after EBRT shows good responseNovember 15, 2021Prostate Cancer
Lenvatinib tops sorafenib for progression-free survival in HCCNovember 15, 2021Hepatocellular Carcinoma
Transarterial chemoembolization plus percutaneous microwave ablation optimizes outcomes for unresectable HCCNovember 15, 2021Hepatocellular Carcinoma
Reduction hepatectomy plus multidisciplinary therapy improves HCC outcomesNovember 15, 2021Hepatocellular Carcinoma
Atezolizumab plus bevacizumab benefits subset of HCC patients as first-line therapyNovember 15, 2021Hepatocellular Carcinoma
Complete response after TACE predicts survival for new HCC patientsNovember 15, 2021Hepatocellular Carcinoma